How safe is your DNA?
By Anne Marie Green,
CBS News
| 04. 15. 2017
A new high-tech, controversial law enforcement procedure has some people worried it threatens the privacy of our DNA
I first learned about the 20-year-old murder of Angie Dodge in a roundabout way, after getting my DNA analyzed by one of those commercial DNA databases. When I got my results back I was not surprised. There were no big revelations and, just as I suspected, I am not related to royalty. But I did wonder if I could learn anything more from the DNA report. That search sent me down a rabbit hole that lead me to the story of Michael Usry Jr., a young filmmaker who became a suspect in the Angie Dodge murder investigation.
After getting my DNA report I learned that there are a number of genealogy sites, educational institutions and companies that are willing to offer you further insight into what your DNA may reveal, as long as you’re willing to upload your DNA profile to them. Some of these sites charge money, while others are simply willing to analyze your DNA profile in exchange for adding...
Related Articles
By Sarah Zhang, The Atlantic | 03.18.2024
People are discovering the truth about their biological parents with DNA—and learning that incest is far more common than many think.
When Steve Edsel was a boy, his adoptive parents kept a scrapbook of newspaper clippings in their bedroom closet...
By Antonio Regalado, MIT Technology Review | 03.20.2024
There is a new most expensive drug ever—a gene therapy that costs as much as a Brooklyn brownstone or a Miami mansion, and more than the average person will earn in a lifetime.
Lenmeldy is a gene treatment for metachromatic...
By Carl Zimmer, The New York Times | 03.10.2024
In 1889, a French doctor named Francois-Gilbert Viault climbed down from a mountain in the Andes, drew blood from his arm and inspected it under a microscope. Dr. Viault’s red blood cells, which ferry oxygen, had surged 42 percent. He...
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...